decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
seed logo
FAQs NIH Staff Contact & Help

Artery Therapeutics

Artery Therapeutics, Inc. (Artery), a clinical-stage biotechnology company headquartered in the San Francisco Bay area, develops proprietary therapeutics for mainly neurodegenerative diseases, including apolipoprotein E4 (APOE4)-driven dementia and Alzheimer's disease. The company's novel peptide library is derived from ApoE. Its safe and effective peptides are designed to manipulate the ABCA1 (ATP-binding cassette) transporter, thereby altering cell membrane composition and functionality of monocyte-macrophage cells, including glial cells in the brain. In a Phase 1 study of 66 subjects with and without the APOE4 risk factor, CS6253 demonstrated a favorable safety profile and pharmacokinetics. Artery Therapeutics is partially sponsored by NIH-NIA and Alzheimer’s Association Part the Cloud. 
Contact Name:
Jonas Johansson
Contact Email:
[email protected]
Website: https://www.arterytx.com/
City, State – Congressional District: San Ramon,
CA
–
10
Technology: Drug
Funding: Aging (NIA)
NIH Projects: NIH RePorter for Artery Therapeutics
Sponsored Event(s): Biotech Showcase | 2025
National Institutes of Health
Bethesda, MD 20892

Stay in the Loop

Subscribe to our mailing list for updates on deadlines and important information.

Site Map

Fraud, Waste and Abuse

HHS Vulnerability Disclosure | Technical Issues: E-mail OER Webmaster